142 related articles for article (PubMed ID: 31896551)
41. Insulin as an autoantigen in NOD/human diabetes.
Zhang L; Nakayama M; Eisenbarth GS
Curr Opin Immunol; 2008 Feb; 20(1):111-8. PubMed ID: 18178393
[TBL] [Abstract][Full Text] [Related]
42. Thymic self-antigens for the design of a negative/tolerogenic self-vaccination against type 1 diabetes.
Geenen V; Mottet M; Dardenne O; Kermani H; Martens H; Francois JM; Galleni M; Hober D; Rahmouni S; Moutschen M
Curr Opin Pharmacol; 2010 Aug; 10(4):461-72. PubMed ID: 20434402
[TBL] [Abstract][Full Text] [Related]
43. The sentinel role of CD8 T cells in regulating CD4 T cell responses to proinsulin in beta-islet cell autoimmunity.
Batarelo V; Durinovic-Belló I
Ann N Y Acad Sci; 2008 Dec; 1150():270-2. PubMed ID: 19120311
[TBL] [Abstract][Full Text] [Related]
44. Intranasal vaccination with proinsulin DNA induces regulatory CD4+ T cells that prevent experimental autoimmune diabetes.
Every AL; Kramer DR; Mannering SI; Lew AM; Harrison LC
J Immunol; 2006 Apr; 176(8):4608-15. PubMed ID: 16585551
[TBL] [Abstract][Full Text] [Related]
45. Predominantly recognized proinsulin T helper cell epitopes in individuals with and without islet cell autoimmunity.
Durinovic-Belló I; Boehm BO; Ziegler AG
J Autoimmun; 2002 Feb; 18(1):55-66. PubMed ID: 11869047
[TBL] [Abstract][Full Text] [Related]
46. GM-CSF producing autoreactive CD4
Knoop J; Gavrisan A; Kuehn D; Reinhardt J; Heinrich M; Hippich M; Eugster A; Ockert C; Ziegler AG; Bonifacio E
Clin Immunol; 2018 Mar; 188():23-30. PubMed ID: 29229565
[TBL] [Abstract][Full Text] [Related]
47. A divergent population of autoantigen-responsive CD4
Heninger AK; Eugster A; Kuehn D; Buettner F; Kuhn M; Lindner A; Dietz S; Jergens S; Wilhelm C; Beyerlein A; Ziegler AG; Bonifacio E
Sci Transl Med; 2017 Feb; 9(378):. PubMed ID: 28228602
[TBL] [Abstract][Full Text] [Related]
48. Proinsulin-specific T-cell responses correlate with estimated c-peptide and predict partial remission duration in type 1 diabetes.
Musthaffa Y; Hamilton-Williams EE; Nel HJ; Bergot AS; Mehdi AM; Harris M; Thomas R
Clin Transl Immunology; 2021; 10(7):e1315. PubMed ID: 34336205
[TBL] [Abstract][Full Text] [Related]
49. Persistence of Pancreatic Insulin mRNA Expression and Proinsulin Protein in Type 1 Diabetes Pancreata.
Wasserfall C; Nick HS; Campbell-Thompson M; Beachy D; Haataja L; Kusmartseva I; Posgai A; Beery M; Rhodes C; Bonifacio E; Arvan P; Atkinson M
Cell Metab; 2017 Sep; 26(3):568-575.e3. PubMed ID: 28877460
[TBL] [Abstract][Full Text] [Related]
50. Associations of polymorphisms in non-HLA loci with autoantibodies at the diagnosis of type 1 diabetes: INS and IKZF4 associate with insulin autoantibodies.
Lempainen J; Härkönen T; Laine A; Knip M; Ilonen J;
Pediatr Diabetes; 2013 Nov; 14(7):490-6. PubMed ID: 23721563
[TBL] [Abstract][Full Text] [Related]
51. Selective organ specific inflammation in offspring harbouring microchimerism from strongly alloreactive mothers.
Leveque L; Hodgson S; Peyton S; Koyama M; MacDonald KP; Khosrotehrani K
J Autoimmun; 2014 May; 50():51-8. PubMed ID: 24268809
[TBL] [Abstract][Full Text] [Related]
52. Hybrid Insulin Peptides Are Autoantigens in Type 1 Diabetes.
Baker RL; Rihanek M; Hohenstein AC; Nakayama M; Michels A; Gottlieb PA; Haskins K; Delong T
Diabetes; 2019 Sep; 68(9):1830-1840. PubMed ID: 31175101
[TBL] [Abstract][Full Text] [Related]
53. Analyses of regulatory CD4+ CD25+ FOXP3+ T cells and observations from peripheral T cell subpopulation markers during the development of type 1 diabetes in children.
Hamari S; Kirveskoski T; Glumoff V; Kulmala P; Simell O; Knip M; Veijola R
Scand J Immunol; 2016 Apr; 83(4):279-87. PubMed ID: 26888215
[TBL] [Abstract][Full Text] [Related]
54. Beyond the hormone: insulin as an autoimmune target in type 1 diabetes.
Brezar V; Carel JC; Boitard C; Mallone R
Endocr Rev; 2011 Oct; 32(5):623-69. PubMed ID: 21700723
[TBL] [Abstract][Full Text] [Related]
55. Plant-based vaccines for oral delivery of type 1 diabetes-related autoantigens: Evaluating oral tolerance mechanisms and disease prevention in NOD mice.
Posgai AL; Wasserfall CH; Kwon KC; Daniell H; Schatz DA; Atkinson MA
Sci Rep; 2017 Feb; 7():42372. PubMed ID: 28205558
[TBL] [Abstract][Full Text] [Related]
56. In vitro assessment of cord blood-derived proinsulin-specific regulatory T cells for cellular therapy in type 1 diabetes.
Paul M; Dayal D; Bhansali A; Dhaliwal L; Sachdeva N
Cytotherapy; 2018 Nov; 20(11):1355-1370. PubMed ID: 30340983
[TBL] [Abstract][Full Text] [Related]
57. Plasmid-encoded proinsulin preserves C-peptide while specifically reducing proinsulin-specific CD8⁺ T cells in type 1 diabetes.
Roep BO; Solvason N; Gottlieb PA; Abreu JRF; Harrison LC; Eisenbarth GS; Yu L; Leviten M; Hagopian WA; Buse JB; von Herrath M; Quan J; King RS; Robinson WH; Utz PJ; Garren H; ; Steinman L
Sci Transl Med; 2013 Jun; 5(191):191ra82. PubMed ID: 23803704
[TBL] [Abstract][Full Text] [Related]
58. Perinatal autoimmunity in offspring of diabetic parents. The German Multicenter BABY-DIAB study: detection of humoral immune responses to islet antigens in early childhood.
Roll U; Christie MR; Füchtenbusch M; Payton MA; Hawkes CJ; Ziegler AG
Diabetes; 1996 Jul; 45(7):967-73. PubMed ID: 8666150
[TBL] [Abstract][Full Text] [Related]
59. Relationship between T and B cell responses to proinsulin in human type 1 diabetes.
Durinovic-Belló I; Maisel N; Schlosser M; Kalbacher H; Deeg M; Eiermann T; Karges W; Boehm BO
Ann N Y Acad Sci; 2003 Nov; 1005():288-94. PubMed ID: 14679078
[TBL] [Abstract][Full Text] [Related]
60. Use of autoantigen-loaded phosphatidylserine-liposomes to arrest autoimmunity in type 1 diabetes.
Pujol-Autonell I; Serracant-Prat A; Cano-Sarabia M; Ampudia RM; Rodriguez-Fernandez S; Sanchez A; Izquierdo C; Stratmann T; Puig-Domingo M; Maspoch D; Verdaguer J; Vives-Pi M
PLoS One; 2015; 10(6):e0127057. PubMed ID: 26039878
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
